Food and Drug Regulations, C.R.C., c. 870
Section C.02.023
Cite as Food and Drug Regulations, C.R.C., c. 870, s. C.02.023 · current to June 17, 2026 · regulation last amended June 17, 2026
Statute Watch
Get an alert when a bill in Parliament would change this section, and every time it moves.
The text
(1) On receipt of a complaint or any information respecting the quality of a drug or its deficiencies or hazards, every fabricator, packager/labeller, wholesaler, distributor referred to in section C.01A.003 and importer of the drug shall make a record of the complaint or information that contains the following:
(a) the results of any investigation carried out under subsection C.02.015(2) and, if applicable, the corrective action taken; or
(b) the name and business address of the person in charge of the quality control department to whom the complaint or information was forwarded under subsection C.02.015(2.1) and the date on which it was forwarded.
(2) Records referred to in subsection (1) shall be retained for the following period unless the person holds an establishment licence that specifies some other period:
(a) in the case of a drug in dosage form, one year after the expiration date of the lot or batch of the drug; and
(b) in the case of an active ingredient,
(i) if the active ingredient has a retest date, three years after the lot or batch has been completely distributed, or
(ii) in any other case, one year after the expiration date of the lot or batch of the active ingredient.
Read the Food and Drug Regulations on the Justice Laws Website ↗
Made under Food and Drugs Act, R.S.C. 1985, c. F-27.
Bills in Parliament that would change this section 0
No bill we hold would amend or repeal this section.